WeBull, 20 Free Stocks When You Sign Up and Refer One Friend
WeBull is a popular trading apps that offer no-fee trades. But, besides free trades, the platform also offers free stocks for new users. And right now they have increased the signup bonuses offering 5 free stocks. WeBull also has a great deal for those who are in two player mode, as they can earn 15 free stocks with just one referral. Let’s take a look at the details.
Signup Offer
This is the current signup bonus for WeBull, with up to 5 free stocks:
- Apply to open a Webull brokerage account between 03/01/2022 – 03/31/2022 and receive 2 free stocks, valued between $3 – $300.Â
- Make an initial deposit of any amount between 03/01/2022 – 03/31/2022 and receive an additional 3 free stocks, each valued between $7 – $3000.
Referral Offer
If you sign up now, or if you already have an WeBull account, you have the option to refer friends and earn more free stocks. A successful referral is a person that signs up with your referral link and completes the same signup bonus requirements listed above. You can only claim your free stocks when your referral’s initial deposit settles. And through March 22, there’s a great referral offer where you can earn 15 free stocks by inviting just one friend, and 10 stock for every friend after that.
So in two player mode, you can sign up for WeBull and get 5 free stocks. Then invite P2 and get 15 free stocks. P2 will also get the 5 free stocks as a signup bonus. That’s a total of 25 free stocks between two people, which should be worth $120 or more.
Related: Free Stock Roundup – A List Of All Of The Free Stock Offers Out There
Conclusion
Even if you don’t plan on trading much, or you already have a brokerage account, this is an easy bonus. It’s also a way to check out WeBull and see if you like the interface and features that it offers.
 Chase Sapphire Preferred® Card
Chase Sapphire Preferred® Card is the old king of travel rewards cards. Right now bonus_miles_fullLearn more about this card and its features!
Opinions, reviews, analyses & recommendations are the author’s alone, and have not been reviewed, endorsed or approved by any of these entities.